Avidity Biosciences, Inc. (RNA): Quarterly Revenue Growth

RNA (Avidity Biosciences Inc) - company brandmark

The quarterly revenue chart on GURU.Markets confirms the transparency of the RNA platform management, where the parameter value equals 299.20. Anticipation of the final trial results for myopathy drugs is driving investor interest, despite the absence of current sales. High barriers to entry in genetic engineering and strict regulatory oversight solidify the status of Avidity Biosciences (RNA) as a monopolist due to its patents.

RNA (Avidity Biosciences Inc) Quarterly Sales Growth Rate history from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Avidity Biosciences, Inc. (RNA)

- current quotes and average value forecast:
Initial company analysis:Avidity Biosciences Inc (RNA)
Mass-produced product of aviditybiosciences.com

For Avidity Biosciences (RNA), which is scaling its portfolio of RNA-based therapies for muscle pathologies, this indicator serves as a leading signal of the business's commercial readiness. The metric measures quarter-over-quarter revenue growth rates with daily updates, allowing the quarterly revenue change indicator to timely identify expansion slowdowns and optimize the portfolio prior to the publication of official financial reports.

Main competitors

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|Revenue Growth QoQ CRISPR Therapeutics|WGS - Revenue Change vs Previous Quarter|Quarterly Revenue Growth RARE|Sales Change QoQ BEAM|Quarterly Revenue Growth SRPT (Sarepta Corp)|TWST - Quarterly Sales Growth|TXG: Quarterly Sales Growth|Quarterly Revenue Growth Rate Intellia Therapeutics|STOK: Quarterly Revenue Growth|BLFS - Quarterly Sales Growth Rate|Quarterly Sales Growth WVE|MAZE: Quarterly Revenue Increase|Revenue Growth QoQ Sionna Corp (SION)|Quarterly Sales Growth Rate Prime Medicine Bio|Quarterly Revenue Growth TSHA (Taysha Gene Therapies Inc)|Quarterly Revenue Growth uniqure.com QURE|MeiraGTx Holdings - Quarterly Revenue Growth|RGNX - Quarterly Revenue Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)